Latest Administration News

Page 28 of 184
AJ Lucas Group Limited has swung to a $38.9 million half-year profit, buoyed by a significant UK settlement and improved Australian drilling operations despite revenue pressures.
Maxwell Dee
Maxwell Dee
27 Feb 2026
FlexiRoam Limited has reported a remarkable turnaround with a net profit of AUD 1.42 million for the half-year ended 31 December 2025, driven by a shift to high-margin recurring revenue and cost discipline. The launch of its AI-powered eSIM agent and key partnerships underpin this transformation.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Memphasys Limited has advanced its Felix™ System commercial rollout with key regulatory approvals and new international contracts, while trimming operating costs and narrowing losses in the first half of FY2026.
Ada Torres
Ada Torres
27 Feb 2026
Lumos Diagnostics reported a 74% increase in its half-year loss to US$4.88 million, despite strong progress with its FebriDx diagnostic test and a landmark US distribution agreement. The company awaits a critical FDA decision that could unlock significant revenue growth.
Ada Torres
Ada Torres
27 Feb 2026
GLG Corp Ltd reported an 18.7% drop in revenue to USD 54.1 million for the half year ended December 2025, resulting in a net loss amid challenging macroeconomic conditions and tariff pressures. Despite operational efficiencies improving gross margins, the company refrained from declaring an interim dividend.
Victor Sage
Victor Sage
27 Feb 2026
Anteris Technologies Global Corp. posted a $94.2 million loss for 2025 amid a 29% revenue decline, while progressing its pivotal DurAVR THV clinical trial and securing $320 million in early 2026 financings.
Ada Torres
Ada Torres
27 Feb 2026
Entropy Neurodynamics reports a 14.8% reduction in half-year losses while progressing a pioneering clinical trial for Binge Eating Disorder using its proprietary psychedelic drug TRP-8803. The company also secured $6.1 million in new funding and strategic collaborations to enhance its neuropsychiatry platform.
Ada Torres
Ada Torres
27 Feb 2026
Strata Investment Holdings plc reported a striking £6.16 million comprehensive profit for 2025, propelled by robust investment portfolio returns and a significant revaluation uplift in its copper royalty assets. Despite operational delays from adverse weather, the company’s strategic focus on high-conviction resource investments and royalties positions it well amid evolving commodity markets.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Mesoblast Limited reported its first commercial sales of FDA-approved Ryoncil, generating $48.7 million in net product sales for the half-year ended December 31, 2025, while reducing its net loss by 16%. The company also secured a $125 million five-year credit facility, restructuring its debt to support ongoing commercialization and development.
Ada Torres
Ada Torres
27 Feb 2026
NobleOak Life Limited reported a robust half-year performance with underlying net profit after tax rising 11% to $9.6 million, driven by strong premium growth and market share gains. However, statutory profit fell 23% due to one-off costs and provisions, prompting a pause on dividends amid strategic transitions.
Victor Sage
Victor Sage
27 Feb 2026
ARC Funds Limited posted a $1 million loss for the half-year ending December 2025, while significantly increasing revenues and expanding its ownership in The Term Deposit Shop to 74.48%. The company raised nearly $1.9 million to support growth initiatives amid ongoing operational challenges.
Claire Turing
Claire Turing
27 Feb 2026
Channel Infrastructure reported steady FY25 financials with record throughput and key project progress, while raising dividends and expanding into Australia via a strategic pipeline stake.
Victor Sage
Victor Sage
27 Feb 2026